| 1 |
Diehl AM, Johns DC, Yang S, Lin H, Yin M, Matelis LA and Lawrence JH. Adenovirus-mediated transfer of CCAAT/enhancer-binding protein-alpha identifies a dominant antiproliferative role for this isoform in hepatocytes, J Biol Chem 1996; 271: 7343-50
DOI
PUBMED
|
| 2 |
Grotewold L and Ruther U. The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death, Embo J 2002; 21: 966-75
DOI
ScienceOn
|
| 3 |
Kulik G, Klippel A and Weber MJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt, Mol Cell Biol 1997; 17: 1595-606
DOI
|
| 4 |
Matsuzawa SI and Reed JC. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses, Mol Cell 2001; 7: 915-26
DOI
ScienceOn
|
| 5 |
Miller DL and Weinstock MA. Nonmelanoma skin cancer in the United States: incidence, J Am Acad Dermatol 1994; 30: 774-8
DOI
ScienceOn
|
| 6 |
Neades R, Cox L and Pelling JC. S-phase arrest in mouse keratinocytes exposed to multiple doses of ultraviolet B/A radiation, Mol Carcinog 1998; 23: 159-67
DOI
ScienceOn
|
| 7 |
Timchenko NA, Wilde M, Iakova P, Albrecht JH and Darlington GJ. E2F/107 and E2F/p130 complexes are regulated by C/EBPalpha in 3T3-L1 adipocytes, Nucleic Acids Res 1999; 27: 3621-3630
DOI
ScienceOn
|
| 8 |
Umek RM, Friedman AD and McKnight SL. CCAAT-enhancer binding protein: A component of a differentiation switch, Science 1991; 251: 288-292
DOI
PUBMED
|
| 9 |
Zhan Q, Carrier F and Fornace AJ, Jr. Induction of cellular p53 activity by DNA -damaging agents and growth arrest. Mol Cell Biol. 1993; 13: 4242-50
DOI
|
| 10 |
Timchenko NA, Wilde M and Darlington GJ. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice, Mol. Cell. Biol 1999; 19: 2936-2945
DOI
|
| 11 |
Ouhtit A, Muller HK, Davis DW, Ullrich SE, McConkey D and Ananthaswamy HN. Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin, Am J Pathol 2000; 156: 201-7
DOI
|
| 12 |
Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ and Ponten J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma, Proc Natl Acad Sci USA 1991; 88: 10124-8
|
| 13 |
Watcharasit P, Bijur GN, Zmijewski JW, Song L, Zmijewska A, Chen X, Johnson GV and Jope RS. Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage, Proc Natl Acad Sci USA 2002; 99: 7951-5
|
| 14 |
Brash DE. Sunlight and the onset of skin cancer, Trends Genet 1997; 13:410-4
DOI
ScienceOn
|
| 15 |
Cohen P and Frame S. The renaissance of GSK3, Nat Rev Mol Cell Biol 2001; 2: 769-76
DOI
ScienceOn
|
| 16 |
Tomizawa M, Wang YQ, Ebara M, Saisho H, Watanabe K, Nakagawara A and Tagawa M. Decreased expression of the CCAAT/enhancer binding protein alpha gene involved in hepatocyte proliferation in human hepatocellular carcinomas, Int J Mol Med 2002; 9: 597-600
|
| 17 |
Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT and Tenen DG. CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors, Mol Cell Biol 1998; 18: 4301-14
DOI
|
| 18 |
Sadot E, Geiger B, Oren M and Ben-Ze'ev A. Downregulation of beta-catenin by activated p53, Mol Cell Biol 2001; 21: 6768-81
DOI
ScienceOn
|
| 19 |
Zhu S, Oh HS, Shim M, Sterneck E, Johnson PF and Smart RC. C/EBPb modulates the early events of keratinocyte differentiation involving growth arrest and keratin I and keratin 10 expression, Mol Cell Biol 1999; 19: 7181-7190
DOI
|
| 20 |
Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ and Timchenko NA. C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4, Mol Cell 2001; 8: 817-28
DOI
ScienceOn
|
| 21 |
Ramji DP and Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation, Biochem J 2002; 365: 561-75
DOI
|
| 22 |
Porse BT, Pedersen TA, Xu X, Lindberg B, Wewer UM, Friis-Hansen L and Nerlov C. E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo, Cell 2001; 107: 247-58
DOI
PUBMED
ScienceOn
|
| 23 |
Frame S and Cohen P. GSK3 takes centre stage more than 20 years after its discovery, Biochem J 2001; 359: 1-16
DOI
ScienceOn
|
| 24 |
Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL and MacDougald OA. Inhibition of adipogenesis by Wnt signaling, Science 2000; 289: 950-3
DOI
PUBMED
ScienceOn
|
| 25 |
Shim M, Powers KL, Ewing SJ, Zhu S and Smart RC. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation, Cancer Res 2005; 65: 861-7
|
| 26 |
Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T and Brash DE. Sunburn and p53 in the onset of skin cancer, Nature 1994; 372: 773-6
DOI
ScienceOn
|
| 27 |
Ramaswamy NT, Ronai Z and Pelling JC. Rapid activation of JNK1 in UV-B irradiated epidermal keratinocytes, Oncogene 1998; 16: 1501-5
DOI
ScienceOn
|
| 28 |
Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD and Tenen DG. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer, Cancer Res 2002; 62: 528-34
|
| 29 |
Yoon K and Smart RC. C/EBPalpha is a DNA damageinducible p53-regulated mediator of the G1 checkpoint in keratinocytes, Mol Cell Biol 2004; 24: 10650-60
DOI
ScienceOn
|
| 30 |
Muller C, Calkhoven CF, Sha X and Leutz A. C/EBPalpha requires a SWI/SNF complex for proliferation arrest, J Biol Chem 2004; 279: 7353-8
DOI
ScienceOn
|
| 31 |
Wang X, Scott E, Sawyers CL and Friedman AD. C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU. I gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts, Blood 1999; 94: 560-71
|
webmaster
